Search Results - "Burvenich IJG"

In silico approach and in vitro study of fangchinoline-induced apoptosis and reactive oxygen species production in HER2-overexpressing breast cancer cells.

Source: Contemporary Oncology / Współczesna Onkologia. 2026, Vol. 30 Issue 1, p1-12. 12p.

Development and biological evaluation of a novel CEACAM6-targeted PET tracer for distinguishing malignant nodules in early-stage lung adenocarcinoma.

Authors: Zhu, Keying Tang, Shimin Pan, Donghui et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jun2025, Vol. 52 Issue 7, p2414-2430. 17p.

Tailoring glioblastoma treatment based on longitudinal analysis of post-surgical tumor microenvironment.

Authors: Bastiancich, Chiara Snacel-Fazy, Emmanuel Fernandez, Samantha et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 11/28/2024, Vol. 43 Issue 1, p1-25. 25p.

Radiolabelling and preclinical characterisation of [⁸⁹Zr]Zr-Df-ATG-101 bispecific to PD-L1/4–1BB.

Authors: Cao, Zhipeng Wichmann, Christian Werner Burvenich, Ingrid Julienne Georgette et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Sep2024, Vol. 51 Issue 11, p3202-3214. 13p.

Radioligand-Antibody Conjugates: Integrating Antibody Engineering, Chelator Chemistry, and Radioligands for Precision Theranosis.

Authors: Khandave PY Gudavalekar PU Das T et al.

Source: Molecular diagnosis & therapy [Mol Diagn Ther] 2026 Mar; Vol. 30 (2), pp. 259-280. Date of Electronic Publication: 2025 Dec 19.

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 101264260 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2000 (Electronic) Linking ISSN: 11771062 NLM ISO Abbreviation: Mol Diagn Ther Subsets: MEDLINE

Automated synthesis of [⁸⁹Zr]ZrCl4, [⁸⁹Zr]ZrDFOSquaramide-bisPh(PSMA) and [⁸⁹Zr]ZrDFOSquaramide-TATE.

Authors: Noor, Asif Roselt, Peter D. McGowan, Emily R. et al.

Source: EJNMMI Radiopharmacy & Chemistry. 5/8/2024, Vol. 9 Issue 1, p1-11. 11p.

Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways.

Authors: Kheraldine, Hadeel Gupta, Ishita Cyprian, Farhan Sachal et al.

Source: Cancer Cell International. 3/2/2024, Vol. 24 Issue 1, p1-15. 15p.

Targeting neutrophils: Mechanism and advances in cancer therapy.

Authors: Yang, Shuaixi Jia, Jiachi Wang, Fuqi et al.

Source: Clinical & Translational Medicine. Mar2024, Vol. 14 Issue 3, p1-16. 16p.

Reprogrammed immuno-metabolic environment of cancer: the driving force of ferroptosis resistance.

Authors: Bhowmick, Sramana Banerjee, Saptak Shridhar, Viji et al.

Source: Molecular Cancer. 6/3/2025, Vol. 24 Issue 1, p1-22. 22p.

Automated radiosynthesis of [⁸⁹Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo.

Authors: Wichmann CW Poniger S Guo N et al.

Source: Nuclear medicine and biology [Nucl Med Biol] 2023 May-Jun; Vol. 120-121, pp. 108351. Date of Electronic Publication: 2023 May 16.

Publication Type: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 9304420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9614 (Electronic) Linking ISSN: 09698051 NLM ISO Abbreviation: Nucl Med Biol Subsets: MEDLINE

⁸⁹Zr-leukocyte labelling for cell trafficking: in vitro and preclinical investigations.

Authors: Kahts, Maryke Guo, Hua Kommidi, Harikrishna et al.

Source: EJNMMI Radiopharmacy & Chemistry. 11/6/2023, Vol. 8 Issue 1, p1-16. 16p.

Advances in brain-targeted delivery strategies and natural product-mediated enhancement of blood–brain barrier permeability.

Authors: Liu, Suyi Jin, Xingyue Ge, Yuanyuan et al.

Source: Journal of Nanobiotechnology. 5/26/2025, Vol. 23 Issue 1, p1-32. 32p.

N-Glycosylation of mGluR6 Modulates Receptor Cell-Surface Transport, G-Protein Coupling, and Interactions With Synaptic Adhesion Molecules.

Authors: Akagi T Ogiwara I Shimohata A et al.

Source: Journal of molecular neuroscience : MN [J Mol Neurosci] 2026 May 27; Vol. 76 (2). Date of Electronic Publication: 2026 May 27.

Publication Type: Journal Article

Journal Info: Publisher: Humana Press Country of Publication: United States NLM ID: 9002991 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-1166 (Electronic) Linking ISSN: 08958696 NLM ISO Abbreviation: J Mol Neurosci Subsets: MEDLINE

Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects.

Authors: Cao, Zhipeng Quazi, Sadia Arora, Sakshi et al.

Source: Journal of Biomedical Science. 1/9/2025, Vol. 32 Issue 1, p1-35. 35p.

Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with ⁸⁹Zr-labelled CI-8993.

Authors: Burvenich, Ingrid Julienne Georgette Wichmann, Christian Werner McDonald, Alexander Franklin et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Nov2024, Vol. 51 Issue 13, p3863-3873. 11p.

The IAP inhibitor GDC-0152 suppresses cell proliferation and induces apoptosis in colon cancer cell lines.

Alternate Title: Інгібітор IAP GDC-0152 пригнічує клітинну проліферацію та індукує апоптоз у лініях клітин раку товстої кишки.

Authors: Özdemir, D. Göksu, S. Baydas, G. et al.

Source: Biopolymers & Cell. 2024, Vol. 40 Issue 4, p288-297. 10p.

The dysregulation of unsaturated fatty acid-based metabolomics in the MNNG-induced malignant transformation of Het-1A cells.

Authors: Zhang, Hu Liu, Qiwei Zhao, Chao et al.

Source: Environmental Science & Pollution Research. Apr2022, Vol. 29 Issue 20, p30159-30168. 10p.

Unlocking drug development: the distinctive roles of PET and SPECT imaging from molecular kinetics to therapeutic response.

Authors: Park SM Park JY Lee TS et al.

Source: Archives of pharmacal research [Arch Pharm Res] 2026 Jan; Vol. 49 (1), pp. 134-157. Date of Electronic Publication: 2025 Dec 20.

Publication Type: Journal Article; Review

Journal Info: Publisher: Pharmaceutical Society of Korea Country of Publication: Korea (South) NLM ID: 8000036 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1976-3786 (Electronic) Linking ISSN: 02536269 NLM ISO Abbreviation: Arch Pharm Res Subsets: MEDLINE

Comparison of approaches for increasing affinity of affibody molecules for imaging of B7-H3: dimerization and affinity maturation.

Authors: Oroujeni, Maryam Carlqvist, Matilda Ryer, Eva et al.

Source: EJNMMI Radiopharmacy & Chemistry. 4/16/2024, Vol. 9 Issue 1, p1-19. 19p.

Preclinical evaluation of an ¹⁸F-labeled N^ε-acryloyllysine piperazide for covalent targeting of transglutaminase 2.

Authors: Wodtke, Robert Laube, Markus Hauser, Sandra et al.

Source: EJNMMI Radiopharmacy & Chemistry. 1/2/2024, Vol. 8 Issue 1, p1-25. 25p.